These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 26828692

  • 1. Evaluating the safety and efficacy of felbamate in the context of a black box warning: A single center experience.
    Shah YD, Singh K, Friedman D, Devinsky O, Kothare SV.
    Epilepsy Behav; 2016 Mar; 56():50-3. PubMed ID: 26828692
    [Abstract] [Full Text] [Related]

  • 2. The rise and fall of felbamate as a treatment for partial epilepsy--aplastic anemia and hepatic failure to blame?
    Thakkar K, Billa G, Rane J, Chudasama H, Goswami S, Shah R.
    Expert Rev Neurother; 2015 Mar; 15(12):1373-5. PubMed ID: 26566191
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Therapeutic drug monitoring of felbamate].
    Tribut O, Bentué-Ferrer D, Verdier MC, le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique.
    Therapie; 2010 Mar; 65(1):35-8. PubMed ID: 20205993
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of felbamate in children under 4 years of age: a retrospective chart review.
    Grosso S, Cordelli DM, Coppola G, Franzoni E, Verrotti A, Berardi R, Balestri P.
    Eur J Neurol; 2008 Sep; 15(9):940-6. PubMed ID: 18637038
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Felbamate in an adult population with severe refractory epilepsy.
    Kearney H, Delanty N.
    Ir Med J; 2009 Sep; 102(10):326-8. PubMed ID: 20108801
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Felbamate: a long-term study in subjects with refractory epilepsy].
    De Romanis F, Sopranzi N.
    Clin Ter; 1997 Mar; 148(3):83-7. PubMed ID: 9377844
    [Abstract] [Full Text] [Related]

  • 12. Is there any future for felbamate treatment?
    Borowicz KK, Piskorska B, Kimber-Trojnar Z, Małek R, Sobieszek G, Czuczwar SJ.
    Pol J Pharmacol; 2004 Mar; 56(3):289-94. PubMed ID: 15215558
    [Abstract] [Full Text] [Related]

  • 13. Felbamate: 1997 update.
    Pellock JM, Brodie MJ.
    Epilepsia; 1997 Dec; 38(12):1261-4. PubMed ID: 9578519
    [No Abstract] [Full Text] [Related]

  • 14. Aplastic anemia in a patient receiving felbamate for complex partial seizures.
    Pennell PB, Ogaily MS, Macdonald RL.
    Neurology; 1995 Mar; 45(3 Pt 1):456-60. PubMed ID: 7898696
    [Abstract] [Full Text] [Related]

  • 15. Felbamate pharmacology and use in epilepsy.
    Burdette DE, Sackellares JC.
    Clin Neuropharmacol; 1994 Oct; 17(5):389-402. PubMed ID: 9316688
    [Abstract] [Full Text] [Related]

  • 16. Felbamate: clinical and molecular aspects of a unique antiepileptic drug.
    Brown WM, Aiken SP.
    Crit Rev Neurobiol; 1998 Oct; 12(3):205-22. PubMed ID: 9847055
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).
    Felbamate Study Group in Lennox-Gastaut Syndrome.
    N Engl J Med; 1993 Jan 07; 328(1):29-33. PubMed ID: 8347179
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Felbamate: perspectives for new antiepileptic treatment].
    Pérez-Miranda J, Aguirre J, Parrilla JL, Pérez Miranda M.
    Rev Neurol; 1995 Jan 07; 23(124):1220-5. PubMed ID: 8556622
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.